Posts by Sandra Ansanay-Alex
Testmate Health Partners with Intermountain Health
Testmate Health and Intermountain Health have announced a strategic partnership and investment to accelerate access to rapid, low-cost molecular tests for sexually transmitted infections (STIs) in the U.S. This collaboration positions Intermountain Health and Testmate Health to bring lab-quality STI diagnostics to at-risk communities. STIs remain a largely silent epidemic, with 80% of chlamydia and…
Read MoreCruise Giant MSC Set To Buy Hirslanden Clinics
The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.
Read MoreNew AI Hub for Brain Health at Campus Biotech
This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.
Read MoreGeneva to Host the 14th IAS Conference on HIV Science in 2027
On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been selected to host the 14th IAS Conference on HIV Science, taking place from 11 to 15 July 2027. This major global gathering — expected to welcome more than 5,000 participants — comes at a critical…
Read MorePacrim Group Acquires Majority Stake in Medropharm AG
Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis.
Read MoreTakeda Unveils New State-of-the-Art Biotech Facility in Neuchâtel
Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility in Neuchâtel — a major investment that strengthens both regional innovation and global access to life-changing therapies. With more than CHF 200 Million invested, this is the largest expansion ever made at the site. Boosting…
Read MoreArtiria Medical Secures CE Mark for it SmartGUIDE™ 014, a Deflectable Guidewire
Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions, has received CE Mark certification under the European Medical Device Regulation (EU MDR). The SmartGUIDE™ 014 is engineered to support physicians in navigating the intricate and delicate blood vessels…
Read MoreBracco, Limula and UNIFR Join Forces to Create Efficient Cancer Cell Therapies
Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging, Limula, a company specialising in the automation of cell therapies, and Professor Nicola Vannini of the University of Fribourg are joining forces to make them more accessible. This public-private partnership is receiving CHF 688,000 in…
Read MoreVivent Biosignals, global leader in digital crop diagnostics, raises CHF 7 Million
Vivent Biosignals, the Vaud-based pioneer of “wearables for plants”, has announced new investment from Agri Investment Fund (AIF), Horticoop, Pymwymic and Swiss private investors. The funding will accelerate Vivent’s commercial scaling of its breakthrough plant biosignal monitoring technology, which is transforming crop management and sustainable food production. “We are thrilled to welcome Agri Investment Fund…
Read MoreThe Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read More